Navigation Links
Cardinal Health Announces Early Tender Results of Debt Tender Offer
Date:9/11/2009

15, 2011 and (3) $1,062.50 per $1,000 principal amount of 6.00% notes due June 15, 2017 tendered. Cardinal Health will fund the purchase of the Allegiance Corporation notes accepted for purchase from cash on hand and will fund the purchase of the Cardinal Health notes accepted for purchase from the cash distribution from CareFusion. The settlement date for Cardinal Health notes accepted for purchase will be Sept. 11, and the settlement date for Allegiance Corporation notes accepted for purchase will be Sept. 14.

The Tender Offer

The tender offer will expire at 11:59 p.m., New York City time, on Sept. 24, unless extended or earlier terminated by Cardinal Health. The settlement date for notes with an acceptance priority level of one that are tendered and accepted after the early tender time, but prior to the expiration time, and for notes with an acceptance priority level of other than one that are tendered and accepted prior to the expiration time, will be promptly after the expiration time, and is expected to be on or about Sept. 25, for notes issued by Cardinal Health, and Sept. 28 for notes issued by Allegiance, unless the tender offer is extended. Tenders of notes submitted after the expiration time will be invalid and will not be accepted.

Notes with an acceptance priority level of other than one validly tendered and not validly withdrawn by the early tender time that are accepted for purchase by Cardinal Health will be eligible to receive the total consideration, which is the sum of the tender offer consideration and the early tender premium, each as described in the Offer to Purchase. Notes validly tendered and not validly withdrawn after the early tender time, but prior to the expiration time, that are accepted for purchase by Cardinal Health will be eligible to receive the tender offer consideration, but will not be eligible to receive the early tender premium.

The amount of
'/>"/>

SOURCE Cardinal Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Medical Technology Company CareFusion Spins Off From Cardinal Health, Begins Trading on NYSE
2. Cardinal Health Completes Spinoff of CareFusion Corp.
3. Cardinal Health Announces $1.2 Billion Debt Tender Offer
4. Cardinal Health Reports Fiscal 2009 Results, Provides Fiscal 2010 Outlook
5. George Barrett Named Chairman and CEO of Cardinal Health
6. NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy
7. Cardinal Health Welcomes Record Number of Attendees at its Annual Independent Pharmacy Trade Show
8. Cardinal Health Announced as Title Sponsor of the Health Connect Partners 2009 Fall Hospital Pharmacy Conference
9. Cardinal Health Names Patricia Morrison Chief Information Officer
10. Cardinal Health Board of Directors Approves CareFusion Spinoff
11. Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ngton) November 20, 2009Emergency medical service ...imated 350,000 cardiac arrests each year. Only 5 ...rest survive. Better quality cardiopulmonary resu...ers may be associated with better patient outcome....he largest clinical research network to study preh...
(Date:11/20/2009)... to one-third buying 90-day supply, study finds ,...ying a three-month supply of prescription drugs is...upply, according to a new study. , U.S. researc...drugs between 2000 and 2005, and found that patien...e-month supply saved an average 29 percent in out-...
(Date:11/20/2009)... Longtime OB/GYN warns against the new bre...eventative Services Task Force. These guidelines m...f human lives. When is it wrong to be safe than so...ntative Services Task Force recommendations, publi...l Medicine, has set off a firestorm in the medical...
(Date:11/20/2009)...NTAIN VIEW, Calif., Nov. 20 /PRNewswire-FirstCall/...ider of system solutions to acute healthcare facil... the 21st Annual Piper Jaffray Healthcare Confere... ,, Omnicell Speakers: Randall A. Lipps, foun...ice president & CFO ,, Date: Tuesday, Dec...
(Date:11/20/2009)...RK, Nov. 20 Today, iconic denim ...announce the launch of a capsule gift giving colle...he holiday season. This collection is inspired by...ospital,s Thanks and Giving® Program, a hol...rages consumers to "give thanks for the healthy ki...
Breaking Medicine News(10 mins):Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Three-Month Supply Lowers Drug Costs 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 2Health News:DKNY JEANS Launches Exclusive Collection With HSN for St. Jude Children's Research Hospital's Thanks and Giving(R) Campaign 3
...roperly clean their lenses to prevent infections t... and sight impairment. , Researchers from Univers... Reserve University School of Medicine have been a... fungi that can be lurking on contact lenses, in t...
...rity analysts today, DuPont (NYSE: DD ) Executive...L. Keefer reviewed the company,s accelerated,growt...s growth rate over,the next three years., "As a m...wth in emerging markets are key growth drivers for...
...ennCare and,Shared Health, Tennessee,s largest pub...e launched a pilot program to introduce ePrescribi...ed throughout the state., The ePrescribing progra...ounties are participating in the,TennCare ePrescri...
...nd wellness a priority at all,levels, staffing, pr..., CHICAGO, March 20 Blue Cross and Blue Shield,o...reflecting cultural,changes spanning all aspects o...through accessible, cost-effective,quality health ...
...ticals, Inc. (Nasdaq: ALSE ) today announced that...ertible Promissory Note Purchase Agreement,dated a...s Gipson, Arthur,Koenig, Ingalls & Snyder Value Pa...ready borrowed from the Purchasers, $5,million fro...
...Cancer,Institute, 1 in 8 women will develop breast...ll die of breast cancer in the United States this ... the leading cause of cancer,deaths in American wo... Your Breast -- Mammograms: A Positive Experience"...
Other Medicine News:Health News:$2.4 million grant for study of corneal infections associated with contact lenses 2Health News:DuPont Chief Financial Officer Reviews Company's Accelerated Growth Plan 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 2Health News:TennCare and Shared Health(R) Partner to Deliver ePrescribing to Rural Physicians 3Health News:Blue Cross and Blue Shield of Illinois Evolves its Role, Commits to Health and Wellness of Members and Communities 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 3Health News:Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Women's Negative Attitudes Toward Mammograms 2
(Date:11/20/2009)...RANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstCall...DX ) today announced the completion of its acquisi...ed company that develops and manufactures molecula..., In May 2009, BD and HandyLab announced an exclus...molecular assays on the HandyLab Jaguar(TM) platfo...
(Date:11/19/2009)...YON, France, Nov. 19 In response t...dangerous and illegal medicines, Operation Pangea ...ERPOL and the World Health Organization,s Internat...ce (IMPACT) to highlight the dangers of buying med...ve resulted in a series of arrests and the seizure...
(Date:11/19/2009)...ABBOTT PARK, Ill., Nov. 19 /PRNewswire-FirstCall/ ... ABT ) as one of its Most Admired Corporate Deal... honored Abbott as its Most Admired Dealmaker in ...e of acquisitions and divestitures since January 2...ed its business portfolio with a focus on high-gro...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3MDS Announces CEO Transition Plan 57467 1MDS Announces CEO Transition Plan 57467 2MDS Announces CEO Transition Plan 57467 3MDS Announces CEO Transition Plan 57467 4Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 1Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 2Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 3Avizent Executive Earns DMEC Partnership Award 57464 1Avizent Executive Earns DMEC Partnership Award 57464 2
..., March 18 Micromet, Inc.,(Nasdaq: MITI ), a bio...ry,antibodies for the treatment of cancer, inflamm... posters will be presented on April 14, 2008,at th...r Research (AACR) to,be held at the San Diego Conv...se recent progress on the company,s proprietary Bi...
...Track to Initiate Phase 2b in Second Quarter of 20...m. Eastern Time -, SAN DIEGO, March 17 Ardea Bio...sitive preliminary results from its,ongoing Phase ...vestigational non-nucleoside reverse transcriptase...eficiency virus (HIV)., Preliminary results from ...
Other Medicine Technology:Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 2Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 3Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 4Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research 5Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 2Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 3Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load 4
The Kisses Tag
PDC Smart™ Label
Single - Use Location Tag
RFID Thermal Labels
Medicine Products: